Statins reverse renal inflammation and endothelial dysfunction induced by chronic high salt intake

Area of Science:

• Nephrology
• Cardiovascular Research
• Pharmacology

Background:

• High salt intake is a known risk factor for cardiovascular and kidney disease.
• High salt intake may cause tissue injury through inflammatory factors, independent of blood pressure.
• HMG-CoA reductase inhibitors (statins) have beneficial lipid-independent effects, including reducing inflammation.

Purpose of the Study:

• To investigate if high salt intake impairs kidney structure and function without hypertension.
• To determine if atorvastatin can reverse these high salt-induced kidney changes.
• To explore the role of nitric oxide and oxidative stress in early salt-induced kidney damage.

Main Methods:

• Rats were fed normal salt or high salt diets for 6 weeks, with or without atorvastatin.
• Measurements included blood pressure, urinary protein, creatinine clearance, and renal vascular reactivity.
• Kidney tissue analysis involved glomerular volume, endothelial nitric oxide synthase (eNOS), and transforming growth factor-beta 1 (TGF-β1) expression.

Main Results:

• High salt intake increased urinary protein excretion and glomerular volume, and decreased renal vasodilatation.
• High salt intake reduced eNOS expression and increased TGF-β1, leading to glomerular sclerosis and inflammation, independent of blood pressure.
• Atorvastatin treatment reversed all observed high salt-induced kidney damage.

Conclusions:

• Long-term high salt intake induces kidney inflammation and hemodynamic changes independent of systolic blood pressure.
• Atorvastatin effectively reverses these early-stage salt-induced kidney injuries.
• The balance of nitric oxide and oxidative stress is critical in the pathophysiology of salt-induced kidney damage.